ODIXa-DVT A Prospective, Randomized, Multinational, Multicenter, Partially Blinded, Parallel-Group, Open-Label Active Comparator Controlled Phase II Dose Finding and Proof of Principle Trial

Trial Profile

ODIXa-DVT A Prospective, Randomized, Multinational, Multicenter, Partially Blinded, Parallel-Group, Open-Label Active Comparator Controlled Phase II Dose Finding and Proof of Principle Trial

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Dec 2014

At a glance

  • Drugs Rivaroxaban (Primary) ; Enoxaparin sodium; Vitamin K antagonists
  • Indications Deep vein thrombosis
  • Focus Proof of concept; Therapeutic Use
  • Acronyms ODIXa-DVT
  • Sponsors Bayer
  • Most Recent Events

    • 06 Feb 2009 Status changed to completed as reported by ClinicalTrials.gov.
    • 06 Feb 2009 New source identitified and integrated (ClinicalTrials.gov).
    • 18 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top